Merck & Co. , Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck & Co. with three other
companies in this sector in the United States:
sales of $38.31 billion
of which 66%
was innovative medicines), and
Merck & Co. reported sales of $39.81 billion
December of 2016.
a very small
increase of 0.8%
versus 2015, when the company's sales were $39.50 billion.
Despite this increase, sales are still
below the level achieved in 2014, when Merck & Co.
reported sales of $42.24 billion.